ABCELLERA BIOLOGICS INC (ABCL) Stock Institutional Trading Activity


ABCELLERA BIOLOGICS INC (ABCL) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Renaissance Technologies LLC, Polen Capital Management, and Viking Global Investors. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2025Polen Capital ManagementSell-166,740102,508$350,577
Q4 2025Renaissance Technologies LLCSell-971,5002,389,229$8,171,163
Q3 2025Polen Capital ManagementBuy269,248269,248$1,354,317
Q3 2025Renaissance Technologies LLCBuy53,3003,360,729$16,904,467
Q2 2025Renaissance Technologies LLCBuy413,4003,307,429$11,344,481
Q1 2025Renaissance Technologies LLCBuy407,1362,894,029$6,453,685
Q4 2024Renaissance Technologies LLCSell-459,8102,486,893$7,286,596
Q3 2024Renaissance Technologies LLCBuy1,218,1002,946,703$7,661,428
Q2 2024Renaissance Technologies LLCBuy239,0001,728,603$5,116,665
Q1 2024Renaissance Technologies LLCBuy30,1001,489,603$6,748
Q4 2023Renaissance Technologies LLCSell-232,5501,459,503$8,334
Q3 2023Renaissance Technologies LLCSell-844,5501,692,053$7,783
Q2 2023Renaissance Technologies LLCSell-274,9002,536,603$16,386
Q1 2023Renaissance Technologies LLCBuy689,1002,811,503$21,199
Q4 2022Renaissance Technologies LLCSell-858,4002,122,403$21,500
Q3 2022Renaissance Technologies LLCSell-1,055,5002,980,803$29,480
Q2 2022Renaissance Technologies LLCBuy1,418,7004,036,303$42,987
Q1 2022Renaissance Technologies LLCBuy2,078,4002,617,603$25,522
Q4 2021Renaissance Technologies LLCBuy454,903539,203$7,711
Q3 2021Renaissance Technologies LLCSell-318,90084,300$1,689
Q2 2021Renaissance Technologies LLCBuy403,200403,200$8,870
Q1 2021Viking Global InvestorsSell-200,00019,083,744$648,084
Q4 2020Viking Global InvestorsBuy19,283,74419,283,744$775,978

Frequently asked questions about ABCL activity

  • Which institutional owners are buying ABCL?

    Institutional owners buying ABCL include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ABCL activity?

    "Buy" means an investor increased their reported position in ABCL compared to the prior reporting period. This reflects growing exposure to ABCELLERA BIOLOGICS INC (ABCL) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ABCL increasing?

    Institutional interest in ABCL can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.